Your browser doesn't support javascript.
loading
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
Jeong, Youngtae; Hellyer, Jessica A; Stehr, Henning; Hoang, Ngoc T; Niu, Xiaomin; Das, Millie; Padda, Sukhmani K; Ramchandran, Kavitha; Neal, Joel W; Wakelee, Heather; Diehn, Maximilian.
Afiliação
  • Jeong Y; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
  • Hellyer JA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.
  • Stehr H; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
  • Hoang NT; Department of New Biology, DGIST, Daegu, Republic of Korea.
  • Niu X; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
  • Das M; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Padda SK; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
  • Ramchandran K; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.
  • Neal JW; Department of Biology, San Francisco State University, San Francisco, California.
  • Wakelee H; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
  • Diehn M; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Clin Cancer Res ; 26(1): 274-281, 2020 01 01.
Article em En | MEDLINE | ID: mdl-31548347

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Fator 2 Relacionado a NF-E2 / Proteína 1 Associada a ECH Semelhante a Kelch / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Fator 2 Relacionado a NF-E2 / Proteína 1 Associada a ECH Semelhante a Kelch / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article